| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 212.87B | 206.81B | 179.46B | 167.28B | 151.28B | 119.26B |
| Gross Profit | 42.93B | 39.78B | 30.55B | 26.02B | 27.39B | 17.52B |
| EBITDA | 33.78B | 33.67B | 26.85B | 21.83B | 21.29B | 13.19B |
| Net Income | 15.64B | 14.92B | 11.31B | 8.85B | 11.45B | 4.64B |
Balance Sheet | ||||||
| Total Assets | 280.37B | 256.37B | 229.96B | 202.39B | 168.33B | 142.04B |
| Cash, Cash Equivalents and Short-Term Investments | 33.64B | 23.15B | 21.60B | 17.58B | 10.70B | 12.37B |
| Total Debt | 113.34B | 87.57B | 79.26B | 75.79B | 67.00B | 68.31B |
| Total Liabilities | 166.06B | 140.76B | 124.50B | 117.92B | 109.64B | 101.43B |
| Stockholders Equity | 106.90B | 108.24B | 98.18B | 77.32B | 58.49B | 40.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.74B | 1.91B | -3.14B | 2.14B | -1.88B |
| Operating Cash Flow | 0.00 | 21.66B | 23.36B | 15.71B | 13.97B | 7.85B |
| Investing Cash Flow | 0.00 | -24.33B | -21.59B | -22.07B | -11.79B | -9.49B |
| Financing Cash Flow | 0.00 | 4.14B | 681.00M | 12.99B | -4.73B | -618.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥735.67B | 12.76 | ― | 0.76% | 15.02% | 46.62% | |
78 Outperform | ¥436.75B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | ¥701.31B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥72.03B | 12.79 | ― | 2.20% | 4.75% | 164.54% | |
70 Outperform | ¥81.55B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | ¥162.28B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |